|
Canada-0-GrocersRetail Azienda Directories
|
Azienda News:
- Fierce Pharma Biopharma News Insights
Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance
- Health Pharma News | Latest Healthcare Stories | Reuters
Find latest healthcare news from every corner of the globe at Reuters com, your online source for breaking international news coverage
- News | PharmExec
In today’s Pharmaceutical Executive Daily, leadership turnover continues across key federal health agencies under the Trump administration, Shionogi enters a $2 billion agreement to acquire rights to Radicava, and the FTC examines antitrust concerns tied to CVS Health’s integrated healthcare model
- Pharma Industry - Latest News, Investigations and Analysis
The latest news on health and wellness, including the healthcare industry, pharmaceuticals and more
- Pharmaceutical Breaking News and Press Releases - Business Wire
Stay updated with the latest press releases on pharmaceuticals, covering industry news, research, and regulatory updates in drug development and healthcare
- Pharmaceuticals sector - Financial Times
Comprehensive coverage of the pharmaceuticals industry The latest news and developments from the world's leading drug companies, including Pfizer, Johnson Johnson, AstraZeneca and more
- News - PharmaTimes
Axplora has announced plans to build a 4,500sqm R D and laboratory hub at its Farmabios site in Gropello Cairoli in Italy DNA Script has signed distribution agreements with Gencell, Bio-Medical Science (BMS) and Biostream, expanding global access to its SYNTAX platform
- Pharma, Biotech and Generics Industry News | The Pharmaletter
Pharma, Biotech and Generics Industry News Important research news last week included US pharma giant Merck Co moving its Winrevair into Phase III for pulmonary arterial hypertension On the M A front, Biogen announced a $5 6 billion takeover for Apellis and its two main products – Empaveli and Syfovre Eli Lilly’s oral obesity drug orforglipron has been granted US Food and Drug
- Pharma Sector News | PharmaVoice
Novartis’ acquisition of Excellergy for up to $2 billion portends a potential new wave of medicines for food allergies The agency is becoming more open about its criticisms of pharma companies and leaders, raising new privacy concerns in the industry
- BioWorld: The Daily Biopharmaceutical and Medical Technology News Source
Daily news and analysis of the global biotechnology, pharmaceutical and medical technology industries
|
|